Millions of fentanyl patches recalled

It's a new blow for the controversial painkiller fentanyl. Johnson & Johnson and Sandoz are recalling defective fentanyl patches that could cause patients or caregivers to overdose. The recall follows a December FDA warning that misuse can cause overdose, and another in July 2005 that instructed patients to follow package instructions strictly to avoid overdosing.

Some of the patches may have a cut in the drug reservoir that could leak potent opioid gel. Exposure to it can lead to respiratory depression and overdose, J&J said in a statement. About 32 million of the patches will be recalled. The FDA says it's investigating.

- see J&J's release about the recall
- read the AP report
- check out more from The Wall Street Journal

Suggested Articles

Imbruvica has enjoyed a nice run in previously untreated CLL over the last few years. But major competition is here in the form of AZ's Calquence.

Pennsylvania's Supreme Court revived thousands of lawsuits alleging the antipsychotic med Risperdal caused males to develop breasts.

In the asthma biologics race, there doesn't appear to be a clear favorite among Xolair, Dupixent, Fasenra and Nucala for a group of pulmonologists.